Reliability of visual assessment by non-expert nuclear medicine physicians and appropriateness of indications of [(123)I]FP-CIT SPECT imaging by neurologists in patients with early...

por Suwijn, Sven R., Verschuur, Constant V. M., Slim, Marleen A., Booij, Jan, de Bie, Rob M. A.
Publicado 2019

Protocol of a randomised delayed-start double-blind placebo-controlled multi-centre trial for Levodopa in EArly Parkinson’s disease: the LEAP-study

por Verschuur, Constant V. M., Suwijn, S. R., Post, B., Dijkgraaf, M., Bloem, B. R., van Hilten, J. J., van Laar, T., Tissingh, G., Deuschl, G., Lang, A. E., de Haan, R. J., de Bie, R. M. A.
Publicado 2015

Value of Clinical Signs in Identifying Patients with Scans without Evidence of Dopaminergic Deficit (SWEDD)

por Suwijn, Sven R., Samim, Hamdia, Eggers, Carsten, Espay, Alberto J., Fox, Susan, Lang, Anthony E., Samuel, Mike, Silverdale, Monty, Verschuur, Constant V.M., Dijk, Joke M., Verberne, Hein J., Booij, Jan, de Bie, Rob M. A.
Publicado 2020

Cost-Effectiveness and Cost-Utility of Early Levodopa in Parkinson’s Disease

por Verschuur, Constant V.M., Suwijn, Sven R., de Haan, Rob J., Boel, Judith A., Post, Bart, Bloem, Bas R., van Hilten, Johannes J., van Laar, Teus, Tissingh, Gerrit, Munts, Alexander, Dijkgraaf, Marcel G.W., de Bie, Rob M.A.
Publicado 2022